Shenzhen Salubris Pharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.
July 25, 2021 at 12:00 pm EDT
Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) announces a share repurchase program. Under the program, the company will repurchase not more than CNY 200 million worth of its Class A shares. The shares will be repurchased at a price not exceeding CNY 33 per share. The repurchases will be funded using the company's own funds. The shares repurchased will be used to implement employee stock ownership plans or equity incentives. The repurchase program will be valid for 12 months.